Multi-omics and network pharmacology reveal Huayu-Tongbi decoction reduced arthritis-related bone erosion
Abstract Background Rheumatoid arthritis (RA), an autoimmune disorder marked by joint inflammation and bone destruction, lacks effective therapies targeting bone erosion. Huayu-Tongbi decoction (HT), a traditional Chinese medicine (TCM) herbal decoction, has been used as a complementary treatment fo...
Saved in:
| Main Authors: | Bozhen Chen, Lu Yang, Houchun Wang, Peng Yu, Mengyang Ma, Meiqi Chen, Yingyan Zhou, Jiaqi Wu, Huasheng Liang, Maojie Wang, Runyue Huang, Yiting He, Qingchun Huang, Xiaohong He |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Chinese Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13020-025-01159-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chinese herbal formula Huayu-Qiangshen-Tongbi decoction ameliorates rheumatoid arthritis through enhancing the release of exosomal miR-125b-5p derived from adipose-derived stem cells by CD63
by: Wu Xiao-dong, et al.
Published: (2025-07-01) -
Yiqi Huayu Jiedu Decoction reduces colorectal cancer liver metastasis by promoting N1 neutrophil chemotaxis
by: Hua-Jian Zhou, et al.
Published: (2025-02-01) -
Breeding report of a new strawberry variety Zhongmei Huayue
by: ZHAO Xia, et al.
Published: (2025-02-01) -
The Adjunctive Efficacy of Fuzheng Huayu Tablet on Portal Hypertension with HBV Related Cirrhosis: A Protocol for a Multicenter Randomized Controlled Trial
by: Li Z, et al.
Published: (2025-06-01) -
Fuzheng Huayu tablets for treating pulmonary fibrosis in post-COVID-19 patients: a multicenter, randomized, double-blind, placebo-controlled trial
by: Fei Jing, et al.
Published: (2025-03-01)